Cancer Stem/Progenitor Cell Active Compound 8-Quinolinol in Combination With Paclitaxel Achieves an Improved Cure of Breast Cancer in the Mouse Model

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-008-0072-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Combination Immunotherapy With Extract of Heated 4T1 and Naloxone in Mouse Model of Breast Cancer

Turkish Journal of Medical Sciences
Medicine
2016English

Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Neuregulin-1 Induces Cancer Stem Cell Characteristics in Breast Cancer Cell Lines

Oncology Reports
MedicineCancer ResearchOncology
2014English

A Multiple Breast Cancer Stem Cell Model to Predict Recurrence of T1–3, N0 Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

P3-027Liver Cirrhosis Associated With Paclitaxel and Bevacizumab Combination Therapy in a Metastatic Breast Cancer Patient

Annals of Oncology
MedicineOncologyHematology
2018English

Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer

PLoS ONE
Multidisciplinary
2012English

Evaluation of the Efficacy of Paclitaxel With Curcumin Combination in Ovarian Cancer Cells

Oncology Letters
Cancer ResearchOncology
2016English

The Telomerase Inhibitor Imetelstat Alone, and in Combination With Trastuzumab, Decreases the Cancer Stem Cell Population and Self-Renewal of HER2+ Breast Cancer Cells

Breast Cancer Research and Treatment
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy